The IBN SINA Pharmaceutical Industry PLC announcements
340 Dhaka Stock Exchange announcements for The IBN SINA Pharmaceutical Industry PLC (IBNSINA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (25).
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2021 to the respective shareholders.
- Decision to Land Purchase
The company has informed that the Board of Directors has decided to purchase 143 decimal land at Goalbathan Mouza of Kaliakoir, Gazipur. Total Cost of Land is BDT 3,11,96,000.00 only excluding registration fee and other expenses.
- Alpha Credit Rating Limited (AlphaRating) has rated the Company as \"AA-\" in the long term and \"ST-2\" in the short te
Alpha Credit Rating Limited (AlphaRating) has rated the Company as \"AA-\" in the long term and \"ST-2\" in the short term along with a stable outlook based on audited financial statements of the Company as on June 30, 2021 and relevant qualitative information till September 09, 2021.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 4.54 for July-September 2021 as against Tk. 3.25 for July-September 2020. Consolidated NOCFPS was Tk. 3.27 for July-September 2021 as against Tk. 4.78 for July-September 2020. Consolidated NAV per share was Tk. 73.23 as on September 30, 2021 and Tk. 68.69 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2021 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.
- Resumption after record date
Trading of the shares of the Company will resume on 19.10.2021 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 18.10.2021.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 14.10.2021 to 17.10.2021. Trading of the shares of the Company will remain suspended on record date i.e., 18.10.2021.
- Referring to their earlier news disseminated by DSE on 23.04.2017 regarding Sponsors' share portion increase in the Ibn
Referring to their earlier news disseminated by DSE on 23.04.2017 regarding Sponsors' share portion increase in the Ibn Sina Consumer Products Ltd., the Company has further informed that the investment in consumer project being not feasible and viable for the Consumer at present, the Board of Directors has decided to sell out the investment shares as against 40% Shares equivalent to cost of Tk. 6,00,00,000.00, made to The IBN SINA Consumer Product Ltd., (cont.)
- Dividend Declaration
The Board of Directors has recommended 47% Cash dividend for the year ended on June 30, 2021. Date of AGM: 18.11.2021, Time: 9:30 AM, Venue: Digital Platform. Record Date: 18.10.2021. The Company has also reported Consolidated EPS of Tk. 15.66, Consolidated NAV per share of Tk. 68.69 and Consolidated NOCFPS of Tk. 17.67 for the year ended on June 30, 2021 as against Tk. 12.56, Tk. 56.88 and Tk. 15.92 respectively for the same period of the previous year.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (22.09.2021) following its corporate declaration.
- Decision to Land Purchase (Correction)
(Correction): Referring to the new disseminated earlier, this is to inform all concern that the Company will purchase land instead of sell. Other information shall remain unchanged.
- Decision to sell out the investment shares
(continuation news of IBNSINA): subject to approval by the shareholders pursuant to the notification of BSEC dated 22 March, 2021 for the related party transaction held between The IBN SINA Pharmaceutical Industry Ltd. and The IBN SINA Consumer Product Ltd. (end)
The first part of this announcement is missing from the archive. - Decision to sell land
The company has informed the Board of Directors has decided to construct sales depot of the Company the procurement of a plot of land measuring area of 16.75 decimals situated at Vhuighor Mowza, Fotullah Thana, Narayangonj, Bangladesh at the cost of Tk. 1,50,00,000.00 only excluding registration fee and other relevant charges.
- Updating information
The Company has requested the shareholders bearing BO ID to update their respective BO Accounts with 12 digits e-TIN number and address through their respective DPs before the record date and shareholders bearing Folio Number are requested to submit their 12 digits e-TIN certificate to the share department of the Company latest by October 18, 2021; failing which Income Tax (AIT) at source will be deducted from cash dividend @ 15% instead of 10% as per the Rule.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on September 21, 2021 at 3:15 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- The Company has informed that Mr. M Ataur Rahman, one of the Nominated Directors of the Company passed away on 20.03.202
The Company has informed that Mr. M Ataur Rahman, one of the Nominated Directors of the Company passed away on 20.03.2021. His present holding is 76,979 shares and these shares will be transmitted to the account of his daughter namely Mrs. Zebun Nasreen Ahmed, by way of nomination.
- (Q3 Un-audited): EPS was Tk. 2.79 for January-March 2021 as against Tk. 2.33 for January-March 2020; EPS was Tk. 10.92 f
(Q3 Un-audited): EPS was Tk. 2.79 for January-March 2021 as against Tk. 2.33 for January-March 2020; EPS was Tk. 10.92 for July 2020-March 2021 as against Tk. 9.63 for July 2019-March 2020. NOCFPS was Tk. 14.17 for July 2020-March 2021 as against Tk. 9.54 for July 2019-March 2020. NAV per share was Tk. 64.08 as on March 31, 2021 and Tk. 56.88 as on June 30, 2020.
- As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 24, 2021 at 12:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.
- Buy Confirmation of a Corporate Sponsor Director
IBN SINA TRUST, one of the Corporate Sponsor Directors of the Company, has further reported that it has completed its buying of 1,00,000 shares of the Company at prevailing market price through Stock Exchange (DSE) as per declaration disseminated on 04.03.2021.
- Buy Declarations of a Corporate Sponsor Director
IBN SINA TRUST, one of the Corporate Sponsor Directors of the Company, has expressed its intention to buy 1,00,000 shares of the Company at prevailing market price (In the Public market) through Stock Exchange (DSE) within next 30 working days, as per Rule-4 of the BSEC (Substantial Acquisition of shares and Takeovers), Rules, 2018.
- (Q2 Un-audited): Consolidated EPS was Tk. 4.95 for October-December 2020 whereas (Solo) Tk. 4.43 for October-December 20
(Q2 Un-audited): Consolidated EPS was Tk. 4.95 for October-December 2020 whereas (Solo) Tk. 4.43 for October-December 2019; Consolidated EPS was Tk. 8.19 for July-December 2020 whereas (Solo) Tk. 7.30 for July-December 2019. Consolidated NOCFPS was Tk. 10.48 for July-December 2020 whereas (Solo) Tk. 3.69 for July-December 2019. Consolidated NAV per share was Tk. 61.23 as on December 31, 2020 and Tk. 56.88 as on June 30, 2020.
- As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 23, 2021 at 12:00 Noon to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.
- The Company has informed that the Board of Directors has decided to form a Subsidiary Company in the name of The IBN Sin
The Company has informed that the Board of Directors has decided to form a Subsidiary Company in the name of The IBN Sina Natural Medicine Ltd. aiming to comply with the legal requirements of the Directorate General of Drug Administration (DGDA), Government of Bangladesh under wholly owned investment of The IBN SINA Pharmaceutical Industry Ltd. subject to completion of all regulatory formalities and approval of the concerned regulatory authorities, (cont.)
- (Continuation news of IBNSINA): where the Board also approved Authorized and paid up capital of the Subsidiary Company r
(Continuation news of IBNSINA): where the Board also approved Authorized and paid up capital of the Subsidiary Company respectively BDT 40.00 crore and BDT 12.00 crore. (end)
The first part of this announcement is missing from the archive.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.